Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

432.74 +5.95 (+1.39%)
Streaming Delayed Price Updated: 2:43 PM EDT, May 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178,338
Open 428.34
Bid (Size) 432.41 (40)
Ask (Size) 432.79 (40)
Prev. Close 426.79
Today's Range 425.82 - 434.86
52wk Range 284.10 - 628.92
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money
From Bleichmar Fonti & Auld LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-24.2%
-24.2%
1 Month
-12.8%
-12.8%
3 Month
-22.9%
-22.9%
6 Month
-27.7%
-27.7%
1 Year
+49.9%
+49.9%

More News

Read More
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
The 5 Most Interesting Analyst Questions From Medpace’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
From Pomerantz LLP
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop
From Bleichmar Fonti & Auld LLP
Via Business Wire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
MEDP Q1 Deep Dive: Rising Cancellations and Bookings Lag Shape 2026 Outlook
Via StockStory
News headline image
Medpace (MEDP) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
These stocks are gapping in today's session ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Medpace’s (NASDAQ:MEDP) Q1 CY2026 Sales Beat Estimates But Stock Drops 19.8%
Via StockStory
Topics Earnings
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Medpace (MEDP) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MEDP
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
From Pomerantz LLP
Via GlobeNewswire
News headline image
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After President Allegedly Oversaw Misleading Disclosures: Levi & Korsinsky
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Medpace (MEDP) Q1 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
MEDPACE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Medpace Holdings, Inc. - Common Stock publicly traded?
Yes, Medpace Holdings, Inc. - Common Stock is publicly traded.
What exchange does Medpace Holdings, Inc. - Common Stock trade on?
Medpace Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medpace Holdings, Inc. - Common Stock?
The ticker symbol for Medpace Holdings, Inc. - Common Stock is MEDP on the Nasdaq Stock Market
What is the current price of Medpace Holdings, Inc. - Common Stock?
The current price of Medpace Holdings, Inc. - Common Stock is 432.74
When was Medpace Holdings, Inc. - Common Stock last traded?
The last trade of Medpace Holdings, Inc. - Common Stock was at 05/07/26 02:43 PM ET
What is the market capitalization of Medpace Holdings, Inc. - Common Stock?
The market capitalization of Medpace Holdings, Inc. - Common Stock is 13.41B
How many shares of Medpace Holdings, Inc. - Common Stock are outstanding?
Medpace Holdings, Inc. - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.